Ainos Seeks Shareholder Nod for 950K Stock Awards, Auditor Ratification
Ticker: AIMDW · Form: DEF 14A · Filed: Oct 1, 2025 · CIK: 1014763
| Field | Detail |
|---|---|
| Company | Ainos, INC. (AIMDW) |
| Form Type | DEF 14A |
| Filed Date | Oct 1, 2025 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | mixed |
Sentiment: mixed
Topics: Proxy Statement, Shareholder Meeting, Stock Awards, Dilution Risk, Corporate Governance, Auditor Ratification, Nasdaq Compliance
Related Tickers: AIMDW
TL;DR
**Ainos is asking shareholders to approve a massive 19.9% stock award pool, which is a red flag for dilution, so vote AGAINST Proposal 3.**
AI Summary
Ainos, Inc. (AIMDW) is holding its Annual Meeting of Stockholders on November 7, 2025, in Taiwan, with a record date of September 17, 2025. Key proposals include the election of directors, the ratification of YCM CPA INC. as the independent registered public accounting firm for fiscal year 2024, and the approval to reserve up to 950,000 shares of common stock for special awards outside the 2023 Stock Incentive Plan, as per Nasdaq Listing Rule 5635(c). As of the record date, there were 4,771,184 shares of Common Stock outstanding and entitled to vote. The Board recommends a 'FOR' vote on all proposals, including the special stock awards, which could dilute existing shareholder value by up to 19.9% if fully issued (950,000 shares / 4,771,184 shares). The company is covering all proxy solicitation costs, and preliminary voting results will be announced at the meeting and filed on Form 8-K within four business days.
Why It Matters
This DEF 14A filing outlines critical governance decisions for Ainos, Inc., directly impacting investors through potential dilution from the proposed 950,000 special stock awards, which represents a significant 19.9% of outstanding shares. The ratification of YCM CPA INC. as auditor is standard but essential for financial transparency and regulatory compliance. For employees, the stock awards could serve as an incentive, aligning their interests with company performance. In a competitive market, such awards are often used to attract and retain talent, but the scale of this proposal warrants close investor scrutiny regarding its long-term value creation versus immediate dilution.
Risk Assessment
Risk Level: medium — The proposal to reserve up to 950,000 shares for special stock awards, which are not under the existing 2023 Stock Incentive Plan, represents a significant potential dilution of approximately 19.9% of the 4,771,184 shares outstanding as of September 17, 2025. While the Board recommends 'FOR,' this level of potential dilution without specific details on recipients or performance metrics presents a medium risk to existing shareholder value.
Analyst Insight
Investors should carefully evaluate Proposal 3 regarding the 950,000 special stock awards. Given the potential 19.9% dilution, shareholders should consider voting 'AGAINST' this proposal unless more specific details on the awards' purpose, recipients, and performance conditions are provided to justify such a substantial increase in outstanding shares.
Key Numbers
- 950,000 — Shares of common stock reserved for special awards (Potential dilution not under the 2023 Stock Incentive Plan)
- 4,771,184 — Shares of Common Stock outstanding (Entitled to vote as of the September 17, 2025 Record Date)
- November 7, 2025 — Date of Annual Meeting (Meeting to be held at 5:30 p.m. Taiwan Standard Time)
- September 17, 2025 — Record Date (Date for determining stockholders entitled to vote)
- 19.9% — Potential dilution from special stock awards (Calculated as 950,000 shares / 4,771,184 shares outstanding)
- 2024 — Fiscal year for auditor ratification (YCM CPA INC. appointed for the fiscal year ending December 31, 2024)
- October 1, 2025 — Filing Date of DEF 14A (Date the proxy statement was filed)
- October 10, 2025 — Approximate mailing date of proxy materials (Mailing date for Proxy Statement and 2024 Annual Report)
- June 8, 2026 — Deadline for stockholder proposals for next year (Submission deadline for inclusion in 2026 proxy materials)
- 1 — Vote per share of Common Stock (Each holder of Common Stock is entitled to one vote per share)
Key Players & Entities
- Ainos, Inc. (company) — Registrant and issuer of common stock
- YCM CPA INC. (company) — Independent registered public accounting firm for fiscal year 2024
- Chun-Hsien Tsai (person) — Chief Executive Officer of Ainos, Inc.
- Nasdaq Listing Rule 5635(c) (regulator) — Rule governing the approval of special stock awards
- Securities and Exchange Commission (regulator) — Regulatory body for SEC filings
- Equiniti Trust Company, LLC (company) — Stock transfer agent for Ainos, Inc.
- Broadridge Investor Communications Services (company) — Provider for householding and vote counting
- 8880 Rio San Diego Drive, Ste.800, San Diego, CA (company) — Headquarters address of Ainos, Inc.
- 10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302, Taiwan (R.O.C.) (company) — Location of the Annual Meeting
- Texas (company) — State of incorporation for Ainos, Inc.
FAQ
What are the key proposals for Ainos, Inc.'s Annual Meeting on November 7, 2025?
The key proposals for Ainos, Inc.'s Annual Meeting on November 7, 2025, include the election of directors, the ratification of YCM CPA INC. as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval to reserve up to 950,000 shares of common stock for special awards.
What is the potential dilution from the proposed special stock awards for Ainos, Inc. shareholders?
The proposed reservation of up to 950,000 shares of common stock for special awards represents a potential dilution of approximately 19.9% of the 4,771,184 shares outstanding as of the September 17, 2025 record date.
Who is Ainos, Inc.'s independent registered public accounting firm for fiscal year 2024?
Ainos, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024, is YCM CPA INC., whose appointment is subject to shareholder ratification at the Annual Meeting.
When is the record date for voting at Ainos, Inc.'s 2025 Annual Meeting?
The record date for determining stockholders entitled to notice of and to vote at Ainos, Inc.'s 2025 Annual Meeting is the close of business on September 17, 2025.
Where will Ainos, Inc.'s Annual Meeting be held?
Ainos, Inc.'s Annual Meeting will be held at 5:30 p.m. Taiwan Standard Time on November 7, 2025, at 10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302, Taiwan (R.O.C.).
How many shares of Ainos, Inc. Common Stock were outstanding as of the record date?
As of the record date, September 17, 2025, there were 4,771,184 shares of Ainos, Inc. Common Stock outstanding and entitled to vote at the Annual Meeting.
What is the Board's recommendation on the proposals for Ainos, Inc.'s Annual Meeting?
The Board of Directors recommends a 'FOR ALL' vote for the nominated candidates for directors, 'FOR' the ratification of YCM CPA INC., 'FOR' the approval of the 950,000 special stock awards, and 'FOR' the authorization to adjourn the Annual Meeting.
What is the deadline for Ainos, Inc. stockholders to submit proposals for the 2026 Annual Meeting?
To be considered for inclusion in Ainos, Inc.'s 2026 proxy materials, stockholders must submit their proposals in writing no later than June 8, 2026, to the company's San Diego address.
How can Ainos, Inc. stockholders access the proxy materials and annual report?
Ainos, Inc. stockholders can access the Proxy Statement and the 2024 Annual Report online at www.sec.gov or www.ainos.com, and also at www.proxyvote.com.
What is the voting requirement for Ainos, Inc.'s proposal to approve special stock awards?
The proposal to approve the reservation of up to 950,000 shares for special stock awards requires the affirmative vote of a majority of the shares present or represented by proxy and entitled to vote, meaning 'FOR' votes must exceed 'AGAINST' votes.
Industry Context
Ainos, Inc. operates within the biotechnology and medical device sector, a highly competitive and innovation-driven industry. Companies in this space often rely on significant R&D investment and strategic partnerships to bring new products to market. Regulatory approvals from bodies like the FDA are critical milestones, and the landscape is characterized by rapid technological advancements and evolving healthcare needs.
Regulatory Implications
The company's reliance on Nasdaq listing rules, specifically Rule 5635(c) regarding shareholder approval for equity issuances, highlights the importance of maintaining compliance with exchange regulations. Failure to adhere to these rules could lead to delisting or other sanctions. Furthermore, as a biotechnology company, Ainos is subject to stringent regulatory oversight concerning product development, clinical trials, and market approvals.
What Investors Should Do
- Review the proposals carefully, especially the reservation of 950,000 shares for special awards.
- Vote FOR the ratification of YCM CPA INC. as the independent registered public accounting firm.
- Consider the long-term implications of the proposed special stock awards.
- Familiarize yourself with the voting rights associated with your Common Stock.
Key Dates
- 2025-11-07: Annual Meeting of Stockholders — Key proposals, including director elections and auditor ratification, will be voted on. Potential dilution from special stock awards will be decided.
- 2025-09-17: Record Date — Determines which stockholders are entitled to vote at the Annual Meeting. 4,771,184 shares of Common Stock are outstanding.
- 2024-12-31: Fiscal Year End — The independent auditor, YCM CPA INC., is being ratified for this fiscal year.
- 2025-10-01: DEF 14A Filing Date — The proxy statement detailing the Annual Meeting agenda and proposals was officially filed.
- 2025-10-10: Approximate mailing date of proxy materials — Stockholders received the Proxy Statement and 2024 Annual Report, providing information for voting decisions.
- 2026-06-08: Deadline for stockholder proposals for next year — Sets the deadline for proposals to be included in the 2026 proxy materials, indicating future governance considerations.
Glossary
- DEF 14A
- A proxy statement filed with the SEC by publicly traded companies soliciting shareholder votes for an annual meeting. (This document contains all the information shareholders need to make informed voting decisions on proposals like director elections and stock awards.)
- Common Stock
- A class of stock that represents ownership in a corporation and typically carries voting rights. (The voting power for the Annual Meeting is based on the 4,771,184 shares of Common Stock outstanding.)
- Record Date
- A specific date set by a company to determine which shareholders are eligible to receive dividends or vote at a shareholder meeting. (September 17, 2025, is the record date, meaning only shareholders as of this date can vote on the proposals at the November 7, 2025 meeting.)
- Independent Registered Public Accounting Firm
- An external audit firm that provides assurance on a company's financial statements, independent of management. (YCM CPA INC. is proposed for ratification as the auditor for fiscal year 2024, ensuring the integrity of financial reporting.)
- Nasdaq Listing Rule 5635(c)
- A rule requiring shareholder approval for the issuance or potential issuance of securities that could result in a substantial dilution of existing shareholders' equity. (This rule is cited for the proposal to reserve 950,000 shares for special awards, requiring shareholder approval due to potential dilution.)
- Proxy Solicitation
- The process by which a company requests shareholders to grant it the authority to vote their shares on their behalf. (Ainos, Inc. is covering all costs associated with proxy solicitation for this meeting.)
- Form 8-K
- A report of unscheduled material events or corporate changes filed with the SEC. (Preliminary voting results from the Annual Meeting will be filed on Form 8-K within four business days.)
- Dilution
- The reduction in the ownership percentage of a shareholder that occurs when a company issues new shares. (The proposal to reserve 950,000 shares for special awards could dilute existing shareholders by up to 19.9%.)
Year-Over-Year Comparison
This DEF 14A filing for the November 7, 2025 Annual Meeting focuses on governance and shareholder proposals, including a significant proposal for special stock awards that could lead to a 19.9% dilution. Unlike a typical annual report which would detail financial performance year-over-year, this proxy statement emphasizes the voting agenda. Key metrics such as revenue, net income, and margins are not directly compared to the prior year within this document, but the context of the proposed stock awards suggests a focus on future growth and talent retention, potentially in response to past performance or strategic objectives.
Filing Stats: 4,934 words · 20 min read · ~16 pages · Grade level 10.5 · Accepted 2025-10-01 16:26:19
Key Financial Figures
- $0.01 — s (i) 2,456,319 shares of common stock, $0.01 par value, of Ainos, Inc., a Texas corp
Filing Documents
- formdef14a.htm (DEF 14A) — 470KB
- proxy_001.jpg (GRAPHIC) — 699KB
- proxy_002.jpg (GRAPHIC) — 742KB
- 0001493152-25-016540.txt ( ) — 4795KB
- aimd-20241231.xsd (EX-101.SCH) — 7KB
- aimd-20241231_def.xml (EX-101.DEF) — 12KB
- aimd-20241231_lab.xml (EX-101.LAB) — 69KB
- aimd-20241231_pre.xml (EX-101.PRE) — 46KB
- formdef14a_htm.xml (XML) — 163KB
Security ownership of certain
Security ownership of certain beneficial owners: Ainos Inc. ("Ainos KY") (1) 2,456,319 15.92 % Taiwan Carbon Nano Technology Corporation ("TCNT") (2) 5,500,000 35.64 % ASE Test, Inc. ("ASE Test") (3) 2,312,077 13.05 %
Security ownership of management
Security ownership of management and directors: Chun-Hsien Tsai (1) (4) 551,862 3.58 % Chung-Yi Tsai (1) 54,400 * % Chun-Jung Tsai (1) (4) 327,900 2.12 % Ting-Chuan Lee (1) 331,432 2.15 % Wen-Han Chang (5) 107,733 * % Yao-Chung Chiang (6) 56,400 * % Pao-Sheng Wei 54,400 * % Hsin-Liang Lee 26,376 * % All Directors and Executive Officers as a Group (8 persons) 1,510,503 9.79 % *Represents beneficial ownership of less than 1% (1) Includes (i) 2,456,319 shares of common stock, $0.01 par value, of Ainos, Inc., a Texas corporation (the "Issuer"), owned directly by Ainos Inc., a Cayman Islands company ("Ainos KY"), (ii) 1,265,594 shares pursuant to a Voting Agreement dated January 26, 2024 (the "2024 Voting Agreement"), by and among the Issuer, Ainos Inc., and Chun-Hsien Tsai, Ting Chuan Lee, Chun-Jung Tsai, and Chung-Yi Tsai (the "Tsai Group"); (iii) 153,856 shares of common stock pursuant to a Voting Agreement dated March 7, 2024 (the "2024 Voting Agreement II") with Chih-Heng Lu; (iv) 2,312,077 shares pursuant to a Voting Agreement dated May 3, 2024 between Ainos KY and ASE Test, Inc. and (v) 5,500,000 shares pursuant to a Voting Agreement dated August 15, 2024 between Ainos KY and Taiwan Carbon Nano Technology Corporation. (2) 5,500,000 shares pursuant to a Voting Agreement dated August 15, 2024 between Ainos KY and TCNT. (3) Consisting of the following (i) 29,411 shares owned by ASE Test, (ii) 282,666 shares issuable to ASE Test upon conversion of outstanding convertible notes of the Issuer and (iii) 2,000,000 shares issuable to ASE Test upon conversion of a convertible note of the Issuer issuable within 60 days. All shares beneficially owned by ASE Test are subject to the Voting Agreement dated May 3, 2024 between Ainos KY and ASE Test. (4) Chun-Hsien Tsai and Chun-Jung Tsai serve as directors of Ainos KY; however, they do not control its board, as the board of directors of Ainos KY includes members who are not execut